MeningitisNCT07768982
Clinical Characteristics and Prognostic Factors in Patients With Meningitis at Sohag Governorate.
An observational study of Meningitis, run by Sohag University at 1 site in Egypt.
Trial summary
analyze the clinical characteristics and prognostic factors in patients with meningitis at Sohag Governorate .This is an ambidirectional (retrospective and prospective), hospital-based observational study. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Meningitis
- How many people
- 300 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Aug 2026to 15 Nov 2027
- How long will I take part?
- 2 Weeks
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients diagnosed with meningitis and admitted to Sohag Fever Hospital during the study period, regardless of age or sex, who meet the study eligibility criteria.
Who may be able to join
- All patients diagnosed with meningitis admitted to Sohag Fever Hospital during the study period.
- Patients of all age groups and both sexes.
- Patients with confirmed diagnosis based on clinical features and CSF analysis.
Who cannot join
- Patients with incomplete medical records.
- Patients with uncertain diagnosis of meningitis.
- Patients discharged against medical advice before completion of evaluation.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Analyze of Clinical Characteristics and Prognostic Factors in Patients With Meningitis at Sohag Governorate
analyze the clinical characteristics and prognostic factors in patients with meningitis at Sohag Governorate .This is an ambidirectional (retrospective and prospective), hospital-based observational study. The study involves a retrospective review of patient records over the past 3 years, combined with a prospective recruitment of new patients for one year from the initiation of the study
- Conditions
- Meningitis
- Medical subject headings
- Meningitis
What is being measured
The primary outcome is the main question the study is designed to answer.
All-cause in-hospital mortality
Death from any cause occurring during hospitalization, reported as the number and percentage of participants who died during hospital admission.
Measured: From hospital admission until hospital discharge, up to 30 days.
Secondary outcomes (3)
Recovery without neurological sequelae at hospital discharge
Number and percentage of participants who recover from meningitis without documented neurological sequelae at hospital discharge.
Measured: From hospital admission until hospital discharge, up to 30 days.
Neurological sequelae at hospital discharge
Number and percentage of participants with documented neurological sequelae related to meningitis at hospital discharge.
Measured: From hospital admission until hospital discharge, up to 30 days.
In-hospital complications
Number and percentage of participants who develop complications during hospitalization, with the type of complication recorded.
Measured: From hospital admission until hospital discharge, up to 30 days.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2026
- Study start15 Aug 2026 (estimated)
- Primary completion15 Aug 2027 (estimated)
- Study completion15 Nov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MeningitisStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 300 participants (estimated)
- Target duration
- 2 Weeks
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yehia Atef Khalifa Elsayed, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07768982
- Sponsor's protocol ID
- Soh-Med-26-7-13MS
- Status last verified
- Aug 2026
- First submitted
- 2 Aug 2026
- Last updated
- 17 Aug 2026
- Results posted
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analyze of Clinical Characteristics and Prognostic Factors in Patients With Meningitis at Sohag Governorate
- ClinicalTrials.gov ID
- NCT07768982
- Acronym / sponsor ID
- Soh-Med-26-7-13MS
- Conditions
- Meningitis
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 15 Aug 2026 (estimated)
- Primary completion
- 15 Aug 2027 (estimated)
- Study completion
- 15 Nov 2027 (estimated)
- First posted
- 17 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
analyze the clinical characteristics and prognostic factors in patients with meningitis at Sohag Governorate .This is an ambidirectional (retrospective and prospective), hospital-based observational study. The study involves a retrospective review of patient records over the past 3 years, combined with a prospective recruitment of new patients for one year from the initiation of the study
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Target follow-up
- 2 Weeks
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients diagnosed with meningitis and admitted to Sohag Fever Hospital during the study period, regardless of age or sex, who meet the study eligibility criteria.
Key inclusion criteria (3 listed)
- All patients diagnosed with meningitis admitted to Sohag Fever Hospital during the study period.
- Patients of all age groups and both sexes.
- Patients with confirmed diagnosis based on clinical features and CSF analysis.
Key exclusion criteria (3 listed)
- Patients with incomplete medical records.
- Patients with uncertain diagnosis of meningitis.
- Patients discharged against medical advice before completion of evaluation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
All-cause in-hospital mortality
Time frame: From hospital admission until hospital discharge, up to 30 days.
Death from any cause occurring during hospitalization, reported as the number and percentage of participants who died during hospital admission.
3 secondary outcomes
Recovery without neurological sequelae at hospital discharge
Time frame: From hospital admission until hospital discharge, up to 30 days.
Neurological sequelae at hospital discharge
Time frame: From hospital admission until hospital discharge, up to 30 days.
In-hospital complications
Time frame: From hospital admission until hospital discharge, up to 30 days.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Meningitis
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
RecruitingObservational study
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Rheumatic Diseases, Lupus Erythematosus, Systemic
RecruitingObservational study
Fungal Infection Susceptibility
Cryptococcal Infection, Cryptococcal Pneumonia
RecruitingObservational study
Acute Treatment and Long-term Assessment of Adult Infectious Meningitis
Viral Meningitis, Bacterial Meningitis
RecruitingObservational study
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Idiopathic CD4+ Lymphocytopenia, Cryptococcal Meningitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Meningitis, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact YEHIA ATEF (20010333109026, yehiaatef183@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
All-cause in-hospital mortality (time frame: From hospital admission until hospital discharge, up to 30 days.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.